Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

Women who go through menopause later in life have healthier blood vessels for years to come than those who go through it ...

This prospective case-control study included 85 patients with lung involvement related to the COVID-19 virus and a group of ...

Obstructive sleep apnea is associated with higher rates of age-related macular degeneration development and progression.

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...

Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...

AgreementLotus Pharmaceutical becomes strategic partner for the commercialization of Formycon’s Eylea® biosimilar FYB203/AHZANTIVE® in the Asia-Pacific Region 05.02.2025 / 06:30 CET/CESTThe issuer is ...

The U.S. Food and Drug Administration (FDA) has approved ranibizumab injection (Susvimo, 100 mg/mL; Genentech) for the ...

Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Free Report) saw a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 2,210,000 shares, ...

A simple smoothie with a banana, handful of spinach, almond milk, a teaspoon of turmeric, and a dash of cinnamon is not only ...

Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") .  Such investors are advised to contact Danielle Peyton at ...